To develop and commercialise active cellular immunotherapies under licensed patents, which cover inhibition of Cbl-b in T cells for treatment…
To develop and commercialise active cellular immunotherapies under licensed patents, which cover inhibition of Cbl-b in T cells for treatment…
The approval will enable the company to address $1.2 billion opportunity, starting FY17 Biocon has received European approvals for its…
Amit Sharma receives the award in Life Sciences category The Infosys Science Foundation recently honoured winners of the Infosys Prize…
States that reports are not representative of the pharmaceutical industry as a whole Indian Drug Manufacturers’ Association (IDMA) has reacted…
A slew of activities were held to commemmorate the event
Outlines India’s strategy for elimination of the disease by 2030 JP Nadda, Union Minister for Health & Family Welfare (MoHFW),…
Domestic sales reduced to Rs 1,194 crore Cipla announced its unaudited consolidated financial results for the quarter ended December 31,…
The workshop will be a technical event based primarily around user presentations
The funds raised will be used to advance Invictus’ lead molecule for completion of phase I clinical studies and to…
Sernivo spray is indicated for the treatment of mild to moderate plaque psoriasis in patients 18 years of age or…
The inaugural ceremony of BioAsia 2016 witnessed many strategic partnerships and investment announcements of close to Rs 700 crores The…
Appoints Dr Kamlesh Oza as President – Global Business Development Ideal Cures has opened a representative office in the US…
MediaMedic Communications along with its global partners from GLOBALHealthPR group will present DigiSights 2016. ‘DigiSights 2016’ –an exclusive ‘Digital Marketing…
Subject matter experts from Biocon and BITS Pilani faculty to impart real world insights
Drug makers like GSK have been trying to focus on strengths amid competition from generic drug makers British-based drug maker…
Zeng has over 15 years of academic expertise in the development of stem cell technologies and its applications
The appointment follows in the wake of the successful completion of a phase I clinical trial of the company’s Chikungunya…
Plans to expand its footprints in India